Mental health correlates of drug treatment among women who use methamphetamine

Candalyn B. Rade, Sarah L. Desmarais, Richard A. Van Dorn, Alexandra Lutnick, Alex H. Kral, Jennifer Lorvick

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background and Objectives Women comprise over one-third of people who use methamphetamine in the United States and have a higher prevalence of negative mental health consequences of methamphetamine use than men. Yet, few studies have investigated the mental health correlates of drug treatment among this population. We examined the relationship between mental disorders, mental health treatment, and drug treatment among women who use methamphetamine. Methods We used respondent-driven sampling to recruit women who use methamphetamine (N = 322) for a survey about mental disorders, mental health treatment, drug use and treatment, and sociodemographic factors. Bivariate and multivariable logistic regression analyses were conducted. Results Bivariate analyses indicated that race/ethnicity, mental health treatment, and presence and number of mental disorders were associated with drug treatment. Multivariable analyses revealed that women who reported mental health treatment during a 6-month period had almost twice the odds of also reporting drug treatment than other women (AOR = 1.90; 95% CI = 1.11, 3.25), after controlling for mental disorders and race/ethnicity. Conclusion Among women who use methamphetamine, participation in one service system (mental health treatment) is a key factor in increasing the odds of participation in another service system (drug treatment). Further research should establish the temporal association between mental health and drug treatment. Scientific Significance The present study demonstrates the association between mental health treatment and drug treatment, above and beyond presence or number of mental disorders, and provides direction for drug treatment providers seeking to improve treatment entry and participation among women who use methamphetamine.

Original languageEnglish (US)
Pages (from-to)646-653
Number of pages8
JournalAmerican Journal on Addictions
Volume24
Issue number7
DOIs
StatePublished - Oct 1 2015

Fingerprint

Methamphetamine
Mental Health
Pharmaceutical Preparations
Mental Disorders
Therapeutics
Mental Health Associations
Mental Health Services

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Rade, C. B., Desmarais, S. L., Van Dorn, R. A., Lutnick, A., Kral, A. H., & Lorvick, J. (2015). Mental health correlates of drug treatment among women who use methamphetamine. American Journal on Addictions, 24(7), 646-653. https://doi.org/10.1111/ajad.12279
Rade, Candalyn B. ; Desmarais, Sarah L. ; Van Dorn, Richard A. ; Lutnick, Alexandra ; Kral, Alex H. ; Lorvick, Jennifer. / Mental health correlates of drug treatment among women who use methamphetamine. In: American Journal on Addictions. 2015 ; Vol. 24, No. 7. pp. 646-653.
@article{bbb6222a6ed24608ab7828e99b68db04,
title = "Mental health correlates of drug treatment among women who use methamphetamine",
abstract = "Background and Objectives Women comprise over one-third of people who use methamphetamine in the United States and have a higher prevalence of negative mental health consequences of methamphetamine use than men. Yet, few studies have investigated the mental health correlates of drug treatment among this population. We examined the relationship between mental disorders, mental health treatment, and drug treatment among women who use methamphetamine. Methods We used respondent-driven sampling to recruit women who use methamphetamine (N = 322) for a survey about mental disorders, mental health treatment, drug use and treatment, and sociodemographic factors. Bivariate and multivariable logistic regression analyses were conducted. Results Bivariate analyses indicated that race/ethnicity, mental health treatment, and presence and number of mental disorders were associated with drug treatment. Multivariable analyses revealed that women who reported mental health treatment during a 6-month period had almost twice the odds of also reporting drug treatment than other women (AOR = 1.90; 95{\%} CI = 1.11, 3.25), after controlling for mental disorders and race/ethnicity. Conclusion Among women who use methamphetamine, participation in one service system (mental health treatment) is a key factor in increasing the odds of participation in another service system (drug treatment). Further research should establish the temporal association between mental health and drug treatment. Scientific Significance The present study demonstrates the association between mental health treatment and drug treatment, above and beyond presence or number of mental disorders, and provides direction for drug treatment providers seeking to improve treatment entry and participation among women who use methamphetamine.",
author = "Rade, {Candalyn B.} and Desmarais, {Sarah L.} and {Van Dorn}, {Richard A.} and Alexandra Lutnick and Kral, {Alex H.} and Jennifer Lorvick",
year = "2015",
month = "10",
day = "1",
doi = "10.1111/ajad.12279",
language = "English (US)",
volume = "24",
pages = "646--653",
journal = "American Journal on Addictions",
issn = "1055-0496",
publisher = "Wiley-Blackwell",
number = "7",

}

Rade, CB, Desmarais, SL, Van Dorn, RA, Lutnick, A, Kral, AH & Lorvick, J 2015, 'Mental health correlates of drug treatment among women who use methamphetamine', American Journal on Addictions, vol. 24, no. 7, pp. 646-653. https://doi.org/10.1111/ajad.12279

Mental health correlates of drug treatment among women who use methamphetamine. / Rade, Candalyn B.; Desmarais, Sarah L.; Van Dorn, Richard A.; Lutnick, Alexandra; Kral, Alex H.; Lorvick, Jennifer.

In: American Journal on Addictions, Vol. 24, No. 7, 01.10.2015, p. 646-653.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mental health correlates of drug treatment among women who use methamphetamine

AU - Rade, Candalyn B.

AU - Desmarais, Sarah L.

AU - Van Dorn, Richard A.

AU - Lutnick, Alexandra

AU - Kral, Alex H.

AU - Lorvick, Jennifer

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background and Objectives Women comprise over one-third of people who use methamphetamine in the United States and have a higher prevalence of negative mental health consequences of methamphetamine use than men. Yet, few studies have investigated the mental health correlates of drug treatment among this population. We examined the relationship between mental disorders, mental health treatment, and drug treatment among women who use methamphetamine. Methods We used respondent-driven sampling to recruit women who use methamphetamine (N = 322) for a survey about mental disorders, mental health treatment, drug use and treatment, and sociodemographic factors. Bivariate and multivariable logistic regression analyses were conducted. Results Bivariate analyses indicated that race/ethnicity, mental health treatment, and presence and number of mental disorders were associated with drug treatment. Multivariable analyses revealed that women who reported mental health treatment during a 6-month period had almost twice the odds of also reporting drug treatment than other women (AOR = 1.90; 95% CI = 1.11, 3.25), after controlling for mental disorders and race/ethnicity. Conclusion Among women who use methamphetamine, participation in one service system (mental health treatment) is a key factor in increasing the odds of participation in another service system (drug treatment). Further research should establish the temporal association between mental health and drug treatment. Scientific Significance The present study demonstrates the association between mental health treatment and drug treatment, above and beyond presence or number of mental disorders, and provides direction for drug treatment providers seeking to improve treatment entry and participation among women who use methamphetamine.

AB - Background and Objectives Women comprise over one-third of people who use methamphetamine in the United States and have a higher prevalence of negative mental health consequences of methamphetamine use than men. Yet, few studies have investigated the mental health correlates of drug treatment among this population. We examined the relationship between mental disorders, mental health treatment, and drug treatment among women who use methamphetamine. Methods We used respondent-driven sampling to recruit women who use methamphetamine (N = 322) for a survey about mental disorders, mental health treatment, drug use and treatment, and sociodemographic factors. Bivariate and multivariable logistic regression analyses were conducted. Results Bivariate analyses indicated that race/ethnicity, mental health treatment, and presence and number of mental disorders were associated with drug treatment. Multivariable analyses revealed that women who reported mental health treatment during a 6-month period had almost twice the odds of also reporting drug treatment than other women (AOR = 1.90; 95% CI = 1.11, 3.25), after controlling for mental disorders and race/ethnicity. Conclusion Among women who use methamphetamine, participation in one service system (mental health treatment) is a key factor in increasing the odds of participation in another service system (drug treatment). Further research should establish the temporal association between mental health and drug treatment. Scientific Significance The present study demonstrates the association between mental health treatment and drug treatment, above and beyond presence or number of mental disorders, and provides direction for drug treatment providers seeking to improve treatment entry and participation among women who use methamphetamine.

UR - http://www.scopus.com/inward/record.url?scp=84942550112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942550112&partnerID=8YFLogxK

U2 - 10.1111/ajad.12279

DO - 10.1111/ajad.12279

M3 - Article

C2 - 26300389

AN - SCOPUS:84942550112

VL - 24

SP - 646

EP - 653

JO - American Journal on Addictions

JF - American Journal on Addictions

SN - 1055-0496

IS - 7

ER -